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ABSTRACT
Background. Cross-sectional ﬁndings in community surveys of adults suggest that adolescent
anxiety disorders are strong predictors of the subsequent onset of alcohol use, abuse and depen-
dence. However, prospective data that follow a sample of adolescents into adulthood are needed to
conﬁrm these associations.
Method. Baseline and 4-year follow-up data from the EDSP-Study, a prospective community sur-
vey of 3021 (2548 at follow-up) adolescents and young adults aged 14 to 24 years at baseline carried
out in Munich, were used. DSM-IV anxiety disorders, alcohol use and alcohol use disorders were
assessed with the Munich-Composite-International-Diagnostic-Interview (M-CIDI). Multiple
logistic regression analysis, controlling for age, gender, other mental disorders, substance use dis-
orders and antisocial behaviour was used to study the associations of baseline anxiety disorders
with the subsequent onset and course of alcohol use and alcohol disorders.
Results. Baseline social phobia signiﬁcantly predicts the onsets of regular use and hazardous use
and the persistence of dependence. Panic attacks signiﬁcantly predict the onsets of hazardous use
and abuse as well as the persistence of combined abuse/dependence. Panic disorder signiﬁcantly
predicts the persistence of combined abuse/dependence. Other anxiety disorders do not signiﬁcantly
predict any of the outcomes.
Conclusions. Panic and social phobia are predictors of subsequent alcohol problems among ado-
lescents and young adults. Further studies are needed to investigate the underlying mechanisms
and the potential value of targeted early treatment of primary panic and social phobia to prevent
secondary alcohol use disorders.
INTRODUCTION
Many clinical and epidemiological studies have
documented signiﬁcant cross-sectional relation-
ships between anxiety disorders and alcohol use
disorders (Kushner et al. 1990; Regier et al.
1990; Himle & Hill, 1991; Schneier et al. 1992;
Allan, 1995; Wittchen et al. 1996; Kessler et al.
1997; Swendsen et al. 1998; Kushner et al. 2000).
Meaning and implication of these associations
remain controversial. Discussed mechanisms
are: (a) that anxiety disorder provokes alcohol
use disorder; (b) alcohol use disorder causes
anxiety disorder; and (c) a third shared factor
promotes both conditions (Schuckit & Hessel-
brock, 1994; Kushner et al. 2000). Analysis
of retrospective age-of-onset reports suggests
that the anxiety disorders often start at an
earlier age than the alcohol disorders (Stockwell
et al. 1984; Weiss & Rosenberg, 1985; Wittchen
et al. 1991; Magee et al. 1996; Merikangas et al.
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1998a ; Swendsen et al. 1998; Sareen et al. 2001).
Survival analyses based on these retrospective
reports suggest that early anxiety disorders are
predictors of the subsequent onset and course
of alcohol disorders (Warner et al. 1995; Kessler
& Wittchen, 2000; Kessler et al. 2003). It is
not clear, however, whether these associations
would be conﬁrmed in prospective studies, as
the associations in the retrospective studies
could be due to systematic recall bias. This is a
question of some importance, as the documen-
tation of strong prospective associations would
raise the question whether early treatment of
primary anxiety disorders might be eﬀective in
preventing the onset of secondary alcohol use
disorders.
The results of prospective studies of anxiety
predicting later alcohol outcomes have been
mixed. The vast majority of these studies used
dimensional scales of trait anxiety rather than
diagnostic assessments of anxiety disorders as
the baseline measures (Kammeier et al. 1973;
Ensminger et al. 1982; Hagnell et al. 1986;
Caspi et al. 1996; Vaillant, 1996; Holahan et al.
2001; Kaplow et al. 2001; Poikolainen et al.
2001; Wennberg et al. 2002). Although most
of these studies found that baseline anxiety is
signiﬁcantly associated with elevated levels of
subsequent alcohol use, others did not. One
reason for this inconsistency might be that dif-
ferent anxiety disorders have diﬀerent eﬀects on
alcohol outcomes (Kushner et al. 1990; Clark &
Sayette, 1992; Page & Andrews, 1996). For ex-
ample, Kaplow et al. (2001) found that a base-
line dimensional measure of generalized anxiety
was a positive signiﬁcant predictor of initiation
of alcohol use in a 4-year follow-up study of
936 children who were 9, 11, or 13 at baseline,
while baseline symptoms of separation anxiety
were negative signiﬁcant predictors of the same
outcome.
Two prospective studies have assessed base-
line anxiety using diagnostic interviews. Kush-
ner et al. (1999) assessed 454 college students
for broadly deﬁned DSM-III anxiety disorders
and alcohol use disorders and followed these
students 3 and 6 years later to evaluate changes
in the same outcomes. Baseline anxiety dis-
orders measured globally (i.e. without distin-
guishing among the diﬀerent anxiety disorders)
signiﬁcantly predicted elevated risk of sub-
sequent ﬁrst-onset alcohol disorders at the
follow-ups. Crum & Pratt (2001) evaluated the
eﬀects of baseline social phobia on ﬁrst onset
of heavy alcohol use and alcohol use disorders
over a 13-year follow-up period among the 1161
adults in the Baltimore ECA follow-up sample.
Baseline social phobia did not predict these
outcomes, although baseline subclinical social
phobia was associated with elevated risk of the
onset of all the outcomes.
Neither the Kushner et al. (1999) nor the
Crum & Pratt (2001) studies attempted to dis-
aggregate the eﬀects of multiple anxiety dis-
orders to investigate the existence of speciﬁcities
like those found by Kaplow et al. (2001) and
others (Merikangas et al. 1998b). Crum & Pratt
(2001) had the added problem of studying re-
spondents in an inrestricted age range even
though the retrospective epidemiological data
show that the elevated risk of alcohol disorders
among people with primary anxiety disorders
is limited to adolescence and early adulthood
(Christie et al. 1988; Holly & Wittchen, 1998).
The current investigation was designed to over-
come these limitations by carrying out a dis-
aggregated analysis of the separate eﬀects of
individual anxiety disorders in predicting the
onset and persistence of alcohol use and alcohol
use disorders in a large community epidemiolo-
gical survey of adolescents and young adults
who were assessed at baseline and then re-
assessed over a 4-year follow-up period.
METHOD
Sample
Data come from the Early Developmental
Stages of Psychopathology study (EDSP), a
prospective survey of the onset, persistence, and
correlates of DSM-IV mental disorders in a
representative sample of adolescents and young
adults in Munich, Germany. The EDSP consists
of a baseline survey and two follow-up surveys.
The baseline sample was drawn randomly from
the 1994 government registries of all residents in
the age range 14–24 in metropolitan Munich
and the surrounding counties. As the study was
designed as a longitudinal panel with special
interest in early developmental stages of psy-
chopathology, 14–15-year-olds were sampled at
twice the probability of people 16–21 years of
age and 22–24-year-olds were sampled at half
the probability of the 16–21-year-olds. Details
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about the sampling procedures are presented
elsewhere (Wittchen et al. 1998b ; Lieb et al.
2000). A total of 3021 respondents were inter-
viewed at baseline (T0) with a response rate of
71%. The ﬁrst follow-up study (T1) was con-
ducted only for subjects aged 14–17 at baseline,
whereas the second follow-up study (T2) was
conducted for all subjects. In the ﬁrst follow-up,
an average of 20 months after baseline, a total of
1228 interviews were completed (response rate :
88%). From the 3021 subjects of the baseline
study, a total of 2548 interviews were completed
at the second follow-up, which was conducted
an average of 42 months after baseline (response
rate : 84%). Most frequent reasons for non-
response at baseline as well as at the second
follow-up were refusal (18.2 and 9.2%, respect-
ively), lack of time (3.3 and 1.5%), and failure
to contact (3.1 and 2.7%). Respondents who
responded in both the baseline (T0) and the T2
reinterview are the focus of the current report.
There was no selective attrition due to age,
gender, or geographic distribution, anxiety dis-
orders and alcohol outcomes between the base-
line and second follow-up investigation. A more
detailed discussion of EDSP sample design and
ﬁeld procedures is reported elsewhere (Lieb et al.
2000).
Diagnostic assessment
The diagnostic assessment was based on
the computer-assisted version of the Munich-
Composite-International-Diagnostic-Interview
(DIA-X/M-CIDI) (Wittchen & Pﬁster, 1997),
an updated version of the World Health Orga-
nization’s CIDI version 1.2 (WHO, 1990, 1992).
The M-CIDI allows for the standardized assess-
ment of symptoms, syndromes and diagnoses of
a wide range of DSM-IV disorders along with
information about onset, duration and severity
(APA, 1994). The M-CIDI has good reliability
and validity for all the disorders considered here
(Lachner et al. 1998; Reed et al. 1998; Wittchen
et al. 1998a). Interviews were administered by
highly trained clinical interviewers, most of
whom were clinical psychologists. Interviews
were carried out face-to-face and mostly in the
homes of respondents. At baseline, the M-CIDI
was used to assess lifetime and 12-month dis-
orders. The two follow-up surveys administered
a modiﬁed version of the M-CIDI that covered
only the time interval since the last interview.
DSM-IV anxiety disorders assessed in the
baseline survey include panic disorder with or
without agoraphobia, agoraphobia without
history of panic disorder, social phobia, speciﬁc
phobia, phobia not otherwise speciﬁed (phobia
NOS) and generalized anxiety disorder (GAD).
In addition, results for the DSM-IV-anxiety syn-
drome panic attack are presented.
DSM-IV alcohol use disorders include al-
cohol abuse without dependence and alcohol
dependence with or without alcohol abuse.
As described in more detail elsewhere (Holly
& Wittchen, 1998; Lachner et al. 1998; Nelson
& Wittchen, 1998) lifetime and 12-month al-
cohol use status was deﬁned according to four
commonly used quantity-frequency categories
(Babor et al. 1989; Saunders et al. 1993): (A)
‘Hazardous use’ was deﬁned as an average
use of more than 40 g/day (men) or 20 g/day
(women) of ethanol in the period of peak life-
time use; (B) ‘Regular use’ was deﬁned as using
at least three times a week in the period of peak
lifetime use but never meeting criteria speci-
ﬁed for ‘hazardous’ use ; (C) ‘Occasional use ’
was deﬁned as using >12 times a year but <3
times a week in the peak period; (D) ‘No/sel-
dom use’ was deﬁned as either abstinent or use
that did not qualify for occasional or higher
use categories. The alcohol measures used in the
baseline analyses are respondents’ highest life-
time consumption status, lifetime alcohol abuse,
lifetime alcohol dependence, and comparable
12-month outcomes. The alcohol measures used
in prospective analyses are respondents’ highest
consumption status, incident alcohol abuse
and dependence during the follow-up period
between baseline and the second follow-up
wave. For the 14- to 17-year-olds at baseline,
the follow-up status is assessed from the
aggregation of information obtained from the
ﬁrst and second follow-up interviews. For re-
spondents older than 17 years at baseline,
information on the total follow-up-period stems
from the second follow-up interview.
Additional baseline disorders that were as-
sessed according to DSM-IV and used as con-
trols in the current analyses include major
depressive disorder, dysthymia, bipolar disorder,
and illegal substance use disorders. Lifetime
antisocial behaviour according to the criteria
of DSM-IV antisocial personality disorder
was also used as a control variable. It was only
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assessed at second follow-up by means of a self-
constructed questionnaire based on the German
version of the SKID-II questionnaire and inter-
view concerning antisocial personality disorder
(Fydrich et al. 1997). All control variables were
selected on the basis of an extensive literature
review, where confounding issues of these vari-
ables with regard to the association between
anxiety and alcohol use disorders are discussed
(Schuckit & Hesselbrock, 1994; Merikangas
et al. 1998b ; Kushner et al. 2000).
Statistical analyses
Baseline associations of lifetime anxiety dis-
orders with lifetime alcohol use and alcohol use
disorders were estimated in terms of odds ratios
(OR) based on logistic regressions controlling
for age and gender. Prospective analyses also
used logistic regression to study the associations
of baseline anxiety disorders in predicting the
onset of regular use, hazardous use and alcohol
use disorders in the subsamples of baseline re-
spondents who had never met criteria for these
outcomes. Separate logistic regression analyses
were used to study the associations of baseline
anxiety disorders in predicting the persistence
of alcohol use disorders in the subsample of
respondents with a history of these disorders
at baseline.
The outcomes in the prospective analyses
were deﬁned as the highest outcome measures
between baseline and the 4-year follow-up
period. Cases with alcohol dependence at base-
line with partial remission during follow-up
were classiﬁed as having persistent dependence.
The baseline anxiety disorders used in the initial
analyses were lifetime disorders as of T0. The
eﬀects of the signiﬁcant anxiety disorders were
subsequently disaggregated into the separate
estimated eﬀects associated with disorders that
were active as of T0 (present in the 12 months
before T0) and those that were in remission as
of T0 (not existing in the 12 months before T0
among respondents with a lifetime history of
the particular anxiety disorder). All prediction
equations included controls for age, gender,
other anxiety disorders, major depression, dys-
thymia, bipolar disorders, illegal substance use
disorders and antisocial behaviour. In analyses
of the predictors of regular and hazardous use,
extent of alcohol use at baseline was also con-
trolled. This procedure was done because all
variables might be related to anxiety disorders
as well as to the alcohol outcomes. Additionally,
the eﬀects of the seven anxiety disorders, as a set,
were evaluated globally by Wald chi-squared
tests based on the concerning logistic regression
equation. Diﬀerences between active and re-
mitted anxiety were also tested by Wald chi-
squared tests for diﬀerences in the magnitudes
of pairs of coeﬃcients. Based on evidence that
the associations of negative aﬀect with ado-
lescent alcohol use might diﬀer by gender
(Deykin et al. 1987; Henry et al. 1993; Clark
et al. 1997), interactions of all predictors were
computed with gender.
The data were weighted to adjust for diﬀer-
ential probabilities of selection by age and
for diﬀerential response rates based on the
census population distribution of the cross-
classiﬁcation of age, gender and geographic dis-
tribution at baseline (Wittchen et al. 1998b).
Drop-out between baseline and follow-up was
not markedly related to sex, gender and mental
disorders at baseline. All statistical analyses
were carried out with the STATA (StataCorp.,
2001) software package. The Huber–White
sandwich method for weighted data was used
to adjust signiﬁcance tests for the weighting of
the data (Royall, 1986). Statistical signiﬁcance
was evaluated using 0.05-level two-sided tests.
RESULTS
Prevalences and incidences
Ten per cent of respondents reported lifetime
regular alcohol use and 8.4% reported a lifetime
history of hazardous alcohol use at baseline
(Table 1). In the past 12 months, 9.2% reported
regular alcohol use, while 3.9% reported haz-
ardous use. Lifetime and 12-month prevalences
of alcohol use disorders (see Table 1, 15.9%
and 10.1%, respectively) are higher than the
prevalences of hazardous use, with higher pre-
valences of abuse without dependence (9.7%
lifetime, 5.3% 12-month) than of alcohol de-
pendence (6.2% lifetime, 4.7% 12-month).
The baseline prevalences of having one or
more anxiety disorders (see Table 1, 26.9%
lifetime, 18.2% 12-month) are considerably
higher than the prevalences of baseline alcohol
use disorders. There is wide variation in the
prevalences of individual baseline anxiety dis-
orders, from a high of 16.2% lifetime and
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10.9% 12-month prevalences of speciﬁc phobia
to a low of 1.6% lifetime and 1.2% prevalences
of panic disorder with or without agoraphobia.
First lifetime onset of hazardous use over the
follow-up period (see Table 2) was reported by
6.9% of T2 respondents who had no history of
hazardous use at T0. Between T0 and T2,
36.7% of baseline hazardous users persisted in
their hazardous use. First onset of alcohol abuse
over the follow-upperiodwas reported by 11.9%
of the T2 respondents who had no history of
abuse or dependence as of baseline (Table 2).
First onset of alcohol dependence over the
follow-up period was reported by 3.5% of the
T2 respondents who had no history of depend-
ence as of baseline. Those who met criteria for
dependence at the time of the baseline inter-
view, 25.2% of T0 abusers and 70.1% of T0
respondents, persisted in their abuse and depen-
dence, respectively, between T0 and T2.
Alcohol–anxiety associations at baseline
All baseline anxiety disorders except for phobia
NOS have positive cross-sectional associations
Table 1. Baseline prevalences (N=3021)
Lifetime prevalence 12-month prevalence
%* (95% CI) %* (95% CI)
Alcohol use
No/seldom use 35.2 (33.4–37.0) 41.6 (39.7–43.5)
Occasional use 46.4 (44.4–48.4) 45.3 (43.3–47.3)
Regular use 10.0 (8.8–11.4) 9.2 (8.0–10.6)
Hazardous use 8.4 (7.3–9.8) 3.9 (3.1–4.8)
DSM-IV alcohol use disorders
Abuse (without dependence) 9.7 (8.5–11.1) 5.3 (4.5–6.3)
Dependence 6.2 (5.2–7.3) 4.7 (3.9–5.7)
Any alcohol use disorder 15.9 (14.4–17.5) 10.1 (8.9–11.4)
DSM-IV anxiety disorders
Panic disorder w or w/o agoraphobia 1.6 (1.2–2.3) 1.2 (0.8–1.7)
Panic attack 4.3 (3.6–5.2) 2.7 (2.1–3.4)
Agoraphobia w/o panic disorder 2.3 (1.8–3.0) 1.4 (1.0–2.0)
Social phobia 7.3 (6.3–8.4) 5.2 (4.4–6.2)
Speciﬁc phobia 16.2 (14.8–17.8) 10.9 (9.7–12.2)
Phobia (not otherwise speciﬁed) 5.2 (4.4–6.2) 2.7 (2.1–3.4)
Generalized anxiety disorder 3.4 (2.7–4.3) 1.7 (1.2–2.4)
Any anxiety disorder 26.9 (25.1–28.7) 18.2 (16.7–19.8)
* Values are weighted percentages.






N % (95% CI) N % (95% CI)
Alcohol use
At least regular use 2074 12.3 (10.9–14.0) 457 53.5 (47.7–59.2)
Hazardous use 2323 6.9 (5.8–8.0) 208 36.7 (28.8–45.4)
DSM-IV alcohol use disorders
Alcohol abuse (without dependence) 2141 11.9 (10.6–13.4) 253 25.2 (19.4–32.0)
Alcohol dependence 2394 3.5 (2.8–4.3) 153 70.1 (60.4–78.3)·
Any alcohol use disorder 2141 15.0 (13.5–16.7) 405 58.0 (52.0–63.7)·
Numbers of respondents and percentages are all weighted.
* Data on alcohol use was missing for 15 individuals.
# For example, 2323 respondents without hazardous use at baseline were included in the follow-up sample.
$ For example, 208 respondents with hazardous use at baseline were included in the follow-up sample.
· Cases with dependence at baseline with partial remission during follow-up were classiﬁed as having persistent dependence.
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with all the baseline alcohol outcomes (Table 3).
Approximately half of the ORs are statistically
signiﬁcant at the 0.05 level, using two-sided
tests. ORs are somewhat higher for dependence
than for any of the other alcohol measures. The
number of signiﬁcant ORs progresses sequen-
tially from a low of two for regular use and
abuse to four for hazardous use and ﬁve for
dependence. None of the 35 cross-sectional ORs
varies signiﬁcantly with sex.
Associations between baseline anxiety and the
subsequent onset of alcohol outcomes
The seven lifetime anxiety disorders assessed at
baseline, taken as a set, signiﬁcantly predict the
onset of hazardous use (x27=15.07; P=0.035)
and abuse (x27=14.26; P=0.047) and have
marginally signiﬁcant associations with the on-
set of any alcohol use disorder over the follow-
up period (x27=13.64; P=0.058) (Table 4). The
anxiety disorders are not signiﬁcant predictors,
in comparison, of the onset of regular use or
dependence. Four of the 35 ORs in Table 4 are
signiﬁcant. Two of these four involve panic
attacks and the other two involve social phobia.
All four of these signiﬁcant ORs are >1.0, in-
dicating that panic attacks and social phobia
are associated with an elevated risk of the sub-
sequent onset of the alcohol outcomes.
It is noteworthy that the panic attack ORs are
consistently elevated in predicting all the alcohol
onset outcomes (1.4–2.7), while the ORs as-
sociated with panic disorder are also elevated
in predicting four of the ﬁve outcomes (1.1–3.7),
the exception being regular use. There is no dif-
ference between the ORs associated with panic
attacks and panic disorder in any of the ﬁve
equations (with P values in the range 0.109–
0.888 using two-sided tests). The social phobia
ORs, in comparison, are elevated only in pre-
dicting regular use (1.9) and hazardous use (2.1).
The sign pattern of the ORs for the remaining
four anxiety disorders is statistically random
(ten were >1.0, nine were <1.0, and one was
equal to 1.0). No diﬀerences in any associations
were found for gender.
Associations between baseline anxiety and
persistence of alcohol outcomes
As shown in Table 5, the seven lifetime anxiety
disorders assessed at baseline, taken as a set, sig-
niﬁcantly predict the persistence of any alcohol
disorder (x27=25.53; P=0.001) and are mar-
ginally signiﬁcant predictors of the persistence
of alcohol dependence (x27=12.77; P=0.078).
The anxiety disorders are not signiﬁcant pre-
dictors, in comparison, of the persistence of
regular use, hazardous use, or abuse. In saying
that the anxiety disorders do not signiﬁcantly
predict the persistence of these three outcomes,
it needs to be noted that the small number of
cases involved in the analyses and the skew of
Table 3. Baseline associations (odds ratios) of lifetime DSM-IV Anxiety Disorders with lifetime
alcohol use and DSM-IV Alcohol Use Disorders (N=3021)#
Alcohol use Alcohol use disorders
At least
regular use$ Hazardous use· Abusek Dependence"
Any alcohol use
disorderk
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Panic disorder w or w/o agoraphobia 2.1 (0.8–5.3) 1.7 (0.4–6.1) 1.9 (0.5–6.1) 7.1* (2.4–20.5) 4.1* (1.6–10.1)
Panic attack 4.2* (2.2–7.7) 3.5* (1.7–6.9) 2.6* (1.2–5.5) 6.2* (3.0–12.6) 4.4* (2.4–8.0)
Agoraphobia w/o panic disorder 2.2* (1.0–4.8) 5.0* (2.3–10.9) 2.2 (0.9–5.1) 5.0* (1.9–12.8) 3.3* (1.6–6.7)
Social phobia 1.4 (0.9–2.2) 1.5 (0.8–2.6) 1.2 (0.6–2.2) 2.0* (1.1–3.5) 1.5 (0.9–2.4)
Speciﬁc phobia 1.2 (0.8–1.7) 1.9* (1.3–2.9) 1.6* (1.1–2.4) 2.5* (1.6–3.8) 2.0* (1.4–2.8)
Phobia (not otherwise speciﬁed) 1.2 (0.6–2.2) 1.4 (0.6–2.9) 1.0 (0.4–2.1) 1.6 (0.7–3.5) 1.2 (0.7–2.1)
Generalized anxiety disorder 1.4 (0.7–2.7) 2.2* (1.1–4.4) 1.7 (0.7–3.6) 1.6 (0.6–4.0) 1.8 (0.9–3.5)
OR, Odds ratio adjusted for age and gender.
# Reference group for a particular anxiety disorder, without this particular anxiety disorder; reference group for panic attack, without
panic attack.
$ Reference group, no/occasional use.
· Reference group, not more than regular use.
k Reference group, no alcohol use disorder.
" Reference group, no dependence.
* P<0.05.
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Table 4. Associations (odds ratios) between baseline lifetime DSM-IV Anxiety Disorders and
onset/progression of lifetime alcohol use or DSM-IV Alcohol Use Disorders at follow-up#
Alcohol use Alcohol use disorders
At least
regular use$ Hazardous use· Abusek Dependence"
Any alcohol
use disorder+
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Panic disorder w or w/o agoraphobia 0.6 (0.1–1.9) 1.1 (0.3–3.6) 2.4 (0.4–11.4) 3.7 (0.8–15.9) 2.8 (0.8–9.1)
Panic attack 1.8 (0.7–4.4) 2.5* (1.1–5.8) 2.7* (1.1–6.1) 1.4 (0.2–8.7) 2.0 (0.8–4.7)
Agoraphobia w/o panic disorder 0.6 (0.1–1.9) 1.9 (0.6–5.3) 0.6 (0.1–2.5) 1.2 (0.3–4.4) 0.8 (0.3–2.2)
Social phobia 1.9* (1.0–3.4) 2.1* (1.2–3.8) 0.7 (0.3–1.3) 0.4 (0.1–1.4) 0.6 (0.3–1.1)
Speciﬁc phobia 0.8 (0.5–1.3) 0.9 (0.5–1.4) 1.1 (0.6–1.8) 1.3 (0.6–2.4) 1.1 (0.7–1.8)
Phobia (not otherwise speciﬁed) 0.7 (0.3–1.4) 1.3 (0.6–2.5) 1.1 (0.5–2.3) 1.6 (0.6–4.2) 1.0 (0.4–2.0)
Generalized anxiety disorder 1.5 (0.6–3.4) 1.4 (0.5–3.2) 0.7 (0.2–2.3) 0.7 (0.1–3.5) 0.7 (0.2–2.0)
Any anxiety disorder x27=10.59 x27=15.07* x27=14.26* x27=5.83 x27=13.64
P=0.158 P=0.035 P=0.047 P=0.559 P=0.058
OR, Odds ratio adjusted for age, gender, anxiety disorders, major depressive disorder, dysthymia, bipolar disorders, illegal drug use
disorders, and antisocial behaviour.
# Reference group for a particular anxiety disorder, without this particular anxiety disorder; reference group for panic attack, without
panic attack.
$ At least regular use among baseline non-regular/hazardous users ; reference group, no/occasional use at baseline and during follow-up.
· Hazardous use among baseline non-hazardous users ; reference group, no hazardous use at baseline and during follow-up.
k Abuse among cases without alcohol use disorder at baseline ; reference group, no alcohol use disorder at baseline and during follow-up.
" Dependence among cases without dependence at baseline; reference group, no dependence at baseline and during follow-up.
+ Abuse or dependence among cases without alcohol use disorder at baseline ; reference group, no alcohol use disorder at baseline and
during follow-up.
* P<0.05.
Table 5. Associations (odds ratios) between baseline lifetime DSM-IV Anxiety Disorders and
persistence of lifetime alcohol use or DSM-IV Alcohol Use Disorders at follow-up#
Alcohol use Alcohol use disorders
At least
regular use$ Hazardous use· Abusek Dependence"
Any alcohol use
disorder+
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Panic disorder w or w/o agoraphobia 7.8 (0.7–83.34) 11.0 (0.9–123.3) 3.9 (0.4–37.2) 17.6 (0.2–1222.5) 13.2* (1.4–124.0)
Panic attack 1.2 (0.3–4.0) 0.4 (0.0–4.0) 22.7 (0.8–575.6) 8.1 (0.9–67.3) 18.7* (4.7–73.6)
Agoraphobia w/o panic disorder 0.5 (0.0–3.0) 0.4 (0.0–3.0) 1.7 (0.0–34.8) 0.8 (0.0–10.7) 2.2 (0.3–12.5)
Social phobia 1.7 (0.6–4.5) 1.5 (0.3–6.0) 0.4 (0.0–3.6) 19.7* (1.1–352.2) 2.0 (0.8–4.7)
Speciﬁc phobia 0.7 (0.3–1.5) 0.5 (0.1–1.4) 0.8 (0.2–2.4) 0.7 (0.1–2.7) 0.5 (0.2–1.1)
Phobia (not otherwise speciﬁed) 1.3 (0.4–4.4) 1.6 (0.2–10.1) 3.9 (0.8–17.9) 0.6 (0.0–6.5) 1.8 (0.4–6.6)
Generalized anxiety disorder 1.1 (0.2–3.8) 0.3 (0.0–3.1) — — 0.7 (0.0–8.7) 0.3 (0.0–1.3)
Any anxiety disorder x27=5.50 x27=9.15 x26=8.88 x27=12.77 x27=25.53*
P=0.600 P=0.242 P=0.180 P=0.078 P=0.001
OR, Odds ratio adjusted for age, gender, anxiety disorders, major depressive disorder, dysthymia, bipolar disorders, illegal drug use
disorders, and antisocial behaviour.
# Reference group for a particular anxiety disorder, without this particular anxiety disorder; reference group for panic attack, without
panic attack.
$ At least regular use among baseline regular/hazardous users; reference group, at least regular use at baseline, but not during follow-up.
· Hazardous use among baseline hazardous users; reference group, hazardous use at baseline, but not during follow-up.
k Abuse among cases with abuse at baseline ; reference group, abuse at baseline, but no alcohol use disorder during follow-up.
" Dependence among cases with dependence at baseline ; reference group, dependence at baseline, but not during follow-up.
+ Abuse or dependence among cases with any alcohol disorder at baseline ; reference group, any alcohol use disorder at baseline, but not
during follow-up.
* P<0.05.
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the outcomes reduce statistical power to detect
substantively signiﬁcant eﬀects. Consistent with
this observation, a number of large ORs can
be seen in Table 5 that are not statistically
signiﬁcant.
Three of the 35 odds-ratios in Table 5 are
signiﬁcant at the 0.05 level using two-sided tests.
One of these involves panic attacks, one panic
disorder, and one social phobia. As in Table 4,
there is no diﬀerence between the ORs associ-
ated with panic attacks and panic disorder in
any of the ﬁve equations (with P values in the
range 0.075–0.772). Also consistent with Table 4
is the fact that all three statistically signiﬁcant
ORs are >1.0, indicating that panic attacks,
panic disorder and social phobia are associated
with a elevated risk of the subsequent persist-
ence of the alcohol outcomes. Nine of the ten
panic ORs are elevated in predicting the ﬁve
outcomes (1.2–22.7), the exceptions being panic
attacks in predicting the persistence of at least
harmful use. Four of the ﬁve social phobia ORs
are elevated (1.5–19.7), the exception being the
association between baseline social phobia
and the persistence of alcohol abuse (0.4). The
sign pattern of the ORs for the remaining four
anxiety disorders is largely negative (12 were
<1.0 and seven >1.0). The examination of
interaction with gender of proband revealed
only one eﬀect : among probands with phobia
NOS, risk for persistence of at least regular use
of alcohol was signiﬁcantly reduced in women
but not in men (OR for interaction=0.0; 95%
CI=0.0–0.2; OR for women=0.0; 95% CI=
0.0–0.6; OR for men=5.1; 95% CI=0.8–30.4).
The diﬀerential eﬀects of active and remitted
anxiety disorders
Replications of the results in Tables 4 and 5
were carried out that distinguished between
cases of lifetime (as of T0) panic and social
phobia that were active at the time of the base-
line interview and those that were in remission
at the time of the baseline interview. (Results
not shown, but available on request.) The
number of cases was too small to estimate stable
coeﬃcients to predict persistence (cell sizes
ranged between N=0 and N=29). However, it
was possible to disaggregate the signiﬁcant
eﬀects of panic in predicting the onsets of
hazardous use and abuse into components due
to active and remitted panic. It was also possible
to disaggregate the signiﬁcant eﬀects of social
phobia in predicting the onsets of regular use
and hazardous use into components due to ac-
tive and remitted social phobia. In all of these
cases, remitted panic and social phobia were
found to be as important as active panic and
social phobia in predicting the subsequent al-
cohol outcomes. For example, the OR of T0
remitted panic attack in predicting the sub-
sequent onset of any alcohol use disorder (i.e.
either abuse or dependence) was 2.3 compared
to an OR of 1.8 associated with T0 active panic
attack. None of the tests comparing the ORs
between active and remitted disorders was sig-
niﬁcant (x21=0.03–2.86, P=0.091–0.859). These
results suggest that a history of panic and social
phobia is the important factor in these predic-
tions rather than the current presence of these
disorders at baseline.
DISCUSSION
Consistent with numerous previous reports
based on cross-sectional data (George et al.
1990; Regier et al. 1990; Himle & Hill, 1991;
Kushner & Sher, 1993; Allan, 1995; Kessler
et al. 1997; Kushner et al. 2000), signiﬁ-
cant cross-sectional associations exist between
anxiety disorders and alcohol use disorders in
the EDSP data. Analysis of the prospective
EDSP data, furthermore, document that anxiety
disorders are signiﬁcant predictors of the sub-
sequent onset and persistence of regular and
hazardous alcohol use and alcohol use dis-
orders. Panic and social phobia are the only
anxiety disorders involved in these predictive
associations. As the prospective associations
with onset and persistence were carried out in
separate subsamples, the eﬀects of panic and
social phobia on both sets of outcomes can be
seen as an aﬃrmation of the importance of these
two anxiety disorders for the development of
alcohol problems. It is important to note that
these results were obtained in models that con-
trolled for the confounding eﬀects of other
anxiety disorders, mood disorders, illegal drug
use disorders, antisocial behaviour and demo-
graphic variables.
It is not clear what the processes are that
create these associations. One possibility is that
anxiety disorders are causes of subsequent
alcohol use disorders. The most commonly
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discussed causal processes of this type are that
people with anxiety disorders use alcohol to self-
medicate their anxiety (Quitkin et al. 1972; Cox
et al. 1990; Cowley, 1992; Brady & Lydiard,
1993) or to reduce tension associated with their
anxiety (Conger, 1956; Cappel & Herrman,
1972; Levenson et al. 1980; Sayette, 1999) and
that these processes lead to hazardous use
and alcohol use disorders. Consistent with these
possibilities, a high proportion of people with
anxiety disorders in community surveys report
that they have consciously used alcohol or other
substances tomanage their anxiety (Kessler et al.
2001). However, if these causal processes are
at work, we would expect that active panic and
social phobia would be more important than
remitted panic and social phobia in predicting
alcohol outcomes. We did not ﬁnd this to be
the case in the EDSP. This observation is more
consistent with a second interpretation of the
results : that unmeasured third variables cause
both anxiety disorders and subsequent alcohol
use disorders (Maier et al. 1993; Merikangas
et al. 1996, 1998b). A number of common causes
have also been suggested (Clark & Sayette,
1992; Kendler et al. 1995; Merikangas et al.
1996; Kushner et al. 2000; Holahan et al. 2001).
The results of family aggregation studies re-
ported by Merikangas et al. (1998b) are con-
sistent with the self-medication hypothesis being
a more plausible explanation in the case of social
phobia and shared aetiology more plausible in
the case of panic disorder. Note, that our results
are not contrary to the possibility that alcohol
use disorders can also be risk factors for sub-
sequent anxiety disorders. To clarify this, separ-
ate prospective analyses for testing the eﬀect of
primary alcohol use disorder on the onset and
persistence of subsequent anxiety disorders are
needed (e.g. Kushner et al. 1999).
Although in our sample anxiety disorders are
more prevalent in young women than in men
and alcohol consumption and alcohol use dis-
orders are more prevalent in young men than in
women (Holly &Wittchen, 1998; Wittchen et al.
1998c), no evidence of consistently signiﬁcant
gender diﬀerences was found in our analyses
concerning the associations between anxiety
disorders and alcohol outcomes. Kaplow and
colleagues (2001), in the only other prospec-
tive study of adolescents to examine gender dif-
ferences, also failed to ﬁnd evidence of gender
diﬀerences in the associations between baseline
anxiety and alcohol outcomes in young adult-
hood. This ﬁnding is superﬁcially inconsistent
with the repeated ﬁnding in adult cross-sectional
epidemiological surveys that the co-morbidity
of anxiety disorders with alcoholism is far more
common among women than men (Cooper et al.
1992; Merikangas et al. 1996, 1998b). However,
the latter ﬁnding does not adjust for the fact that
anxiety disorders are signiﬁcantly more com-
mon among women than men.When this adjust-
ment is made and the focus is on relative odds
rather than on prevalences, the evidence of a
gender diﬀerence in the associations between
anxiety disorders and substance disorders among
adults becomes less strong (Kessler, 1997). It
is nonetheless possible that gender diﬀerences
in these associations become larger with age, a
possibility that cannot be evaluated in the EDSP
data due to the truncated upper age range of the
sample.
Interpreting our results we have to consider
that legal access to alcoholic beverages in Ger-
many begins at age 16 and is accompanied by a
relatively widespread acceptance of alcohol use
at this age. In accordance with this, we found
high rates of regular use and hazardous use
among the 14- to 24-year-olds. Despite its legal
prohibition already 26% of the 14- to 15-year-
olds in Germany consumed alcohol 1 to 2 times
a week (Holly & Wittchen, 1998). This is in
contrast, for example, to the United States,
where the legal age for purchasing alcoholic
beverages is 21 years and sales to under-age
consumers are signiﬁcantly sanctioned. So,
ﬁndings from this German sample, are possibly
not generalizable to such populations.
A number of substance abuse researchers
have proposed that outreach and intervention
programs aimed at treating adolescent anxiety
disorders might be cost-eﬀective in preventing
substance use disorders (Kushner et al. 1999;
Crum & Pratt, 2001; Kessler et al. 2003). This
proposal is predicated on the assumption that
anxiety disorders are causal risk factors rather
than non-causal markers. This assumption can
be called into question based on the ﬁnding in
the EDSP data that remitted panic and social
phobia are as important as active panic and
social phobia in predicting alcohol outcomes.
However, it is important to appreciate that this
ﬁnding is not deﬁnitive. In particular, it might
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be that recurrence of these anxiety disorders
subsequent to the baseline assessment promoted
the subsequent outcomes in the subsample of
respondents who were classiﬁed as having re-
mitted panic and social phobia at baseline.
Statistical analyses aimed at investigating this
possibility were attempted but could not be
carried out because of the small number of re-
spondents with baseline remitted panic or social
phobia. Resolution of this uncertainty will re-
quire replication and extension in a larger sam-
ple or over a longer follow-up period.
If this uncertainty is resolved in favour of a
causal interpretation, there would be a number
of practical advantages of early intervention
programmes aimed at the treatment of ado-
lescent anxiety in order to prevent secondary
substance disorders in comparison to more
conventional preventive interventions (Kessler
& Price, 1993). These programmes would allow
prevention researchers to include proven treat-
ment technologies, including pharmacological
and cognitive-behavioural interventions. They
would increase the social warrant for preventive
interventions with critical community constitu-
encies and professional groups because the
programmes would be targeted at youth with
existing disorders. Recipients would be more
open to accepting the interventions than the
recipients of most preventive interventions be-
cause these recipients would already be experi-
encing signiﬁcant distress. These advantages are
suﬃciently compelling that they argue strongly
for other researchers with access to relevant
naturalistic data to carry out parallel studies to
see if adolescent panic and social phobia are,
in fact, reliable predictors of alcohol problems
in early adulthood and, if so, whether there is
evidence to suggest that these associations are
causal.
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